BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 24, 2012
View Archived Issues
Researchers from Canada link CX3CR1 to neural degeneration in CSM
Read More
JNJ-41477670: a novel TRPA1 antagonist with a promising pharmacokinetic profile
Read More
Millennium presents first clinical results for two of its anticancer compounds
Read More
Genetic variations shared between obesity and ADHD identified
Read More
Durable immune responses seen in vivo with HSV-2 vaccine
Read More
Prosensa advances DMD candidates, obtains orphan drug designations
Read More
PTC Therapeutics receives NIH funding for dengue research
Read More
Biotica Technology discloses new cyclophilin A inhibitors
Read More
Amicus achieves target enrollment in phase III migalastat hydrochloride study
Read More
Interim 6-month results of 2-year extension STEPS2 trial presented
Read More
Novel antibacterial agents patented by Brown University
Read More
Lilly reports results from three phase III AWARD trials
Read More
Researchers at GE Healthcare divulge new PET imaging agents
Read More
AIM Therapeutics commences dosing in phase II AIM-102 trial
Read More
Novel TRPV3 channel inhibitors disclosed by Abbott Laboratories
Read More
Merck & Co. patents new compounds for cancer
Read More
Corcept Therapeutics presents new glucocorticoid receptor antagonists
Read More
FDA approves extended-release formulation of oxcarbazepine
Read More
Cel-Sci reports interim review results from phase III Multikine study
Read More
ISTO Technologies plans phase II NuQu study in discogenic back pain
Read More
LabCorp to develop tuberculosis antimicrobial susceptibility test using B-SMART
Read More
Minimally invasive non-small cell lung cancer model devised
Read More
AnGes and Mitsubishi Tanabe Pharma agree on Collategene U.S. rights
Read More
Avanir receives Michael J. Fox Foundation grant to study AVP-923
Read More
SARcode Bioscience discloses topline results from phase III lifitegrast study
Read More
Cosmo Pharmaceuticals reports data from phase II methylene blue MMX study
Read More